Cortical spreading depression (CSD) is a transient synaptic excitation, followed by depression, which can propagate slowly across cortex, subcortex and retina. CSD is implicated in migraine with aura and may lead to migraine pain. CSD can be suppressed by inhibition of both NR2A and NR2B containing N-methyl-D-aspartic acid (NMDA) receptors. However, whether there is a synergistic effect of co-inhibition of NR2A and NR2B containing receptors on CSD remains unknown. In this study, an efficient in vitro model of migraine with intrinsic optical imaging approach was applied to address this role of co-activation of both NR2A and NR2B in CSD. The results showed that co-application of NVP-AAM077, a drug selectively targeting for NR2A and Ro 25-6981, a drug selectively targeting for NR2B containing receptors, showed synergistic inhibitory effects on propagation rate and the magnitude of CSD in a concentration dependent manner in chick retina. Inhibition of CSD propagation was also observed by a clinical acceptable drug that antagonizes both NR2A and NR2B containing receptors, memantine, at 10 µM. These data suggest that combinational use of antagonists selectively targeting NR2A and NR2B containing receptors could be a useful strategy for preventative treatment of migraine with improved efficacy with potential alleviated side effects.
Introduction
Cortical spreading depression (CSD) is a temporary propagating synaptic excitation, followed by depression, which can propagate across cerebral cortex, subcortical regions and retina. CSD is implicated in migraine with aura [1] and may lead to sensitization of migraine pain pathway [2] [3] via both central [4] and peripheral modulations [5] [6] . CSD is accompanied with massive release of neurotransmitters, peptides and cerebral blood flow changes and can also be mediated by key neurotransmitter receptors [7] [8] or neuropeptides [9] [10], pointing them possible therapeutic targets in migraine prophylaxis. Consequently, CSD has been regarded as a useful tool for testing current and novel prophylactic anti-migraine agents [11] .
N-methyl-D-aspartic acid (NMDA) receptors have been recognized as a crucial target against CSD elicitation and propagation as MK801, a nonsubtype-selective channel blocker [12] , shows strong but irreversible suppressive effects on CSD propagation [7] [13] . However, this agent was clinically unacceptable due to its blockade of normal brain function resulting from complete blockade of the channel. NMDA receptors are heteromeric tetramer consisting of two NR1 and two of four NR2 (A-D) and/or one of NR3 (A-B) subunits [14] . Previous studies showed that NR2A-or NR2B-selective NMDA antagonists can partially suppresses CSD both in vitro [8] or in vivo [13] , however with lower efficacy than MK801 [8] [13] . Interestingly, memantine, an non-competitive lowaffinity NMDA receptor channel blocker, first synthesized by Eli Lilly and Company in 1968, which targets both NR2A and NR2B subunits, is clinically well tolerated for treating moderate to severe migraine [15] - [17] and the drug was shown to have anti-CSD effect in rats [13] . We therefore speculate that drugs selectively antagonizing both N2A and NR2B subunits receptor may have greater potential for therapeutic application with improved efficacy and alleviated side effects than competitive channel blockers.
To test this hypothesis, we applied an in vitro efficient CSD migraine model in chick retina complemented with intrinsic optical imaging approach to address synergistic effects of co-application of NR2A-selective and NR2B-selective NMDA receptor antagonists on the magnitude of CSD and propagation rate. The role of these subunits in CSD propagation was also confirmed by memantine in the same tissue.
Methods
Twenty seven male chicks (WuXi Yangzichang Ltd., Wuxi, China) were housed for at least a week before use (aged 8 -28 days). Chick retina preparation from posterior eyecup was as that described previously [18] . All animal procedures were approved by the Ethical Review Panels of Soochow University under agreement with Xi'an Jiaotong-Liverpool University and performed in accordance with the associated guidelines. Efforts were made to minimize animal suffering to reduce animal use.
CSD Induction in Chick Retina with Intrinsic Optical Imaging
Tissue preparation and CSD induction were as that described previously [18] . Briefly, posterior eyecups were positioned in a chamber with temperature kept constant at 32˚C. Unless otherwise stated, the chamber was perfused at 0.5 ml/minute with Ringer's solution (concentrations in mM: 100 NaCl, 6 KCl, 1 MgSO 4 , 30 NaHCO 3 , 1 NaH 2 PO 3 , 1 CaCl 2 and 20 glucose; bubbled with 95% O 2 and 5% CO 2 ; pH 7.3, NaCl was purchased from Fisher Scientific and all other reagents were from Sigma-Aldrich). The tissue was stabilized for at least 30 minutes before elicitation of the first CSD episode. Ten repeated CSD episodes were induced by 0.1 mM KCl with 20-minute interval for tissue recovery. The retina was illuminated for 25 ms every 1 Hz using a high-power LED spotlight (SLS-0307-A, Mightex; Pleasanton, CA, USA) and the illumination was driven by a computer-controlled power supply (Sirius LED controller, SLC-SA04-U; Mightex, Pleasanton, USA). The reflected light was simultaneously recorded with a monochrome camera (QIC-F-M-12, Media Cybernetics, Marlow, UK) used at a maximal spatial resolution. Image sequences were taken at 1 Hz over a 3-minute period, started as CSD was elicited. Camera exposure and illumination were synchronized using the same external trigger (TG5011, TTi, UK). Image Pro Plus software (IPP 7.0; Media Cybernetics, China) was used for image acquisition, storage and analysis.
Experimental Design for Drug Testing
To investigate effects of NVP-AAM077 in the absence or presence of Ro 25-6981, and effects of memantine on CSD magnitude and tissue excitability to CSD in chick retina, four groups were designed: 1) memantine hydrochloride (1-amino-3,5-dimethyladamantane hydrochloride) (Sigma, China) at 1, 3, 10 μM (n = 7) [19] th CSD recording when required, such that the preparation was adequately perfused with proper drug or vehicle for subsequent test (Figure 1). 
Data Presentation and Statistical Analysis
As reported previously [8] , for each 360-frame sequence, an area of interest (AOI) parallel to each CSD wave front was delineated manually (Figure 2) . For each picture within the sequence, the gray levels of the pixels constituting the AOI were averaged and plotted against the time as an indicator to characterize the excitation phase of CSD (Figure 2) . For each CSD wave, the area under the curve (AUC, gray levels × minute) of the transient cellular depolarization was calculated and used as an index of the magnitude of propagating CSD. For each CSD wave, propagation rate was also calculated to reflect the degree of tissue excitability. The calculated values within each different test were averaged and all corresponding data were given as mean ± SD in percentages of their respective baselines, that is, averaged value for the first two K + stimuli. 
Results

Synergistic Suppression of CSD by Co-Application of NVP-AAM077 and Ro 25-6981
In the Ringer's group, there was no significant change in CSD magnitude and propagation rate over repeated CSD episodes throughout the experiment (Figure 3 , n = 7). NVP-AAM077 alone markedly suppressed both -medium in the chick retina. The same area of interest (rectangle within left picture, AOI) was selected and used for all pictures of the sequence under study. All the averaged gray levels within the AOI were plotted against time to generate the CSD wave plot (right). Area under the curve (AUC) of CSD wave front were determined by image analysis to quantify CSD magnitude and propagation rate was calculated as indicated by the distance (D) between two CSD wave fronts within the same AOI at the two different time points over the time duration to quantify drug effects on tissue excitability to CSD. CSD magnitude (Figure 3(a) ) and propagation rate (Figure 3(b) ) in a concentration dependent manner when compared with Ringer's group. At the maximum concentration tested (0.3 μM), the magnitude and propagation rate of CSD was reduced to 51.43% (Figure 3(a) , * p < 0.05) and 64.17% (Figure 3(b) , * p < 0.05) of initial level respectively. This inhibitory effect recovered to 74.06% ( # p < 0.05) and 92.06% of initial level respectively after the drug removal.
Co-application of NVP-AAM077 and Ro 25-6981 produced a synergistic inhibitory effect with a further reduction of CSD magnitude and propagation rate in a concentration dependent manner (Figure 3(a) and Figure  3(b) ). Addition of Ro 25-6981 at the medium concentration applied, 3 μM, brought the CSD magnitude and propagation rate under NVP-AAM077 application at 0.1 μM from insignificance to significance (Figure 3(a) and Figure 3( 
Suppression of CSD by Memantine
Similarly as NVP-AAM077, memantine reduced CSD magnitude and propagation rate (Figure 3 
Discussion
The main finding of this work was that co-application of NVP-AAM077 and Ro 25-6981 showed synergistic inhibitory effects on CSD magnitude and propagation rate, suggesting simultaneous inhibition of NR2A-and NR2B-containing NMDA receptors is a useful strategy for migraine prophylaxis with improved efficacy. The additional inhibitory effect by Ro 25-6981 to NVP-AAM077 on tissue excitability and CSD magnitude in chick retina (Figure 3(a) and Figure 3(b) ) is in consistent with previous findings that NR2B contributes to CSD propagation both in rats using electrophysiology recording [13] , fMRI [21] and intrinsic optical imaging in chick retina [8] . Additionally, this study extended previous findings that inhibition of NR2A alone suppresses tissue excitability to CSD propagation in the same tissue [8] . It was noted that the inhibitory effect on CSD in the chick retina under NR2A inhibition alone by NVP-AAM077 was on contrast to that an unchanged BOLD CSD response was found under NR2A inhibition by TCN-201 [21] . We speculate that this discrepancy may be due to 1) different tissue and species used (rat vs chick retina); and importantly 2) a neuronal mechanism is associated with NR2A mediated CSD in chick retina, a tissue devoid of blood vessel, versus involvement of a vascular component as BOLD signal was dependent on vascular components. Further study is required to clarify the role of NR2A in CSD in vivo.
Memantine was previously shown to inhibit the nociceptive process from trigemino-ophthalmic nerve endings to the trigeminocervical complex in peripheral pain pathway [22] and the drug has efficacy in migraine [15] [16] . In this study, we found a slight but significant suppressive effect by memantine on CSD propagation in chick retina data supporting a neuronal action of NR2A in migraine pathology. This data is compatible with previously published finding in rats [13] and chick retina [23] . As the action of memantine at the concentration applied is associated with both NR2A and NR2B [19] , this result supports that both major subunits are required for CSD propagation, which supports our notion that the synergistic effects observed with co-application of the two antagonists targeting NR2A and NR2B.
Conclusion
In summary, the present study demonstrated a synergistic effect of co-inhibition of NR2A and NR2B containing receptors on CSD in chick retina, suggesting combinational use of selected drugs targeting both the two NR2 subunits may have improved effectiveness in preventive treatment of CSD-associated migraine. Furthermore, both NVP-AAM077 and Ro 25-6981 may have great potential for clinical use against migraine with likely reduced adverse effects, which although requires further investigation in clinic. These data also support that CSD in chick retina with intrinsic optical imaging is a useful tool for assessing drugs targeting NMDA receptor for migraine prophylaxis. However, whether combinational efficacy can be repeated in vivo needs further investigation.
